price
CG
NASDAQ · CGC
Canopy Growth Corporation
Healthcare · Drug Manufacturers - Specialty & Generic
$0.93
Down-$0.00 (-0.25%)
Updated Sep 11, 2026, 9:28 PM
SID Score
3.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 272.15M
- P/E ratio
- -0.58
- Dividend yield
- 0.00%
- 52-week range
- $0.84 – $1.51
- Volume
- 2.99M
- Avg. volume
- 22.65M
Price performance
CGC price history
1M range · 20 trading sessions · Daily adjusted prices
CGC closed at $0.93 after 20 trading sessions, down 7.92% for the selected period.
- Last close
- $0.93
- Period change
- -7.92%
- Period low
- $0.93
- Period high
- $1.07
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 10, 2026 | $0.9488 | $0.9542 | $0.922 | $0.93 | 2.99M |
| Sep 9, 2026 | $0.9655 | $0.9698 | $0.9532 | $0.9594 | 2.27M |
| Sep 8, 2026 | $0.9711 | $0.9976 | $0.9569 | $0.9655 | 2.23M |
| Sep 4, 2026 | $0.9793 | $0.9793 | $0.96 | $0.9727 | 1.9M |
| Sep 3, 2026 | $0.979 | $0.99 | $0.9608 | $0.9729 | 1.71M |
| Sep 2, 2026 | $0.9775 | $0.9936 | $0.9643 | $0.9681 | 1.89M |
| Sep 1, 2026 | $0.9899 | $0.9997 | $0.9659 | $0.9751 | 2.42M |
| Aug 31, 2026 | $0.9938 | $1.01 | $0.9841 | $0.995 | 1.85M |
| Aug 28, 2026 | $1.01 | $1.015 | $0.98 | $0.9995 | 3.84M |
| Aug 27, 2026 | $1.03 | $1.04 | $1.00 | $1.01 | 3.06M |
| Aug 26, 2026 | $1.06 | $1.07 | $1.03 | $1.035 | 2.65M |
| Aug 25, 2026 | $1.06 | $1.08 | $1.045 | $1.07 | 3.14M |
| Aug 24, 2026 | $1.05 | $1.075 | $1.04 | $1.05 | 4.13M |
| Aug 21, 2026 | $1.05 | $1.08 | $1.05 | $1.05 | 5.42M |
| Aug 20, 2026 | $1.04 | $1.06 | $1.01 | $1.05 | 9.01M |
| Aug 19, 2026 | $0.99 | $1.05 | $0.9885 | $1.04 | 7.32M |
| Aug 18, 2026 | $0.9949 | $1.02 | $0.9873 | $0.9897 | 3.6M |
| Aug 17, 2026 | $1.00 | $1.035 | $0.9942 | $1.00 | 4.86M |
| Aug 14, 2026 | $1.01 | $1.02 | $0.9941 | $1.02 | 2.3M |
| Aug 13, 2026 | $1.03 | $1.05 | $1.00 | $1.01 | 4.49M |
Latest CGC news
The latest Smart Investors Daily articles mentioning CGC.
Stock researchResearch & News · Competitors
Loading stock research…